http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-001426-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1892
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B41-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
filingDate 1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3c19f033a42bdb362a63cbf391934f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e1e9997f0283d5aa6a0e85e161aaf53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_236d27ec9259ef2be50e6c67916e94b2
publicationDate 1997-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-001426-A1
titleOfInvention Procedure for the preparation of cis-4-0-protected-2-cyclopentenol derivatives that are useful intermediates in the preparation of various analogs of cyclopentanyl and cyclopentenyl purine that are useful as immunosuppressants, procedures for the preparation of enantiomers of said derivatives and esters Cis-4-o-protected-2-cyclopentenyl and methods for the preparation of enantiomers of cis-4-o-protected cyclopentanol and cis-4-o-protected esters cyclopentanilicos.
abstract The procedure for the preparation of the compound of formula (II) where Pg is selected from the group consisting of benzyl, substituted benzyl, -CH2OCH3, -CH2SCH3, -OCH2OCH2Phenyl, -CH2OCH2CH2OCH3, -CH2OCH2CCl3, -CH (OCH2CH2Cl) 2, CH2OCH2CH2 ) 3, -CH (OC2H5) CH3, -C (OCH3) (CH3) 2, -CH (CH3) OCH (CH3) 2, -CH2CCl3, -C (CH3) 3, -CH2CH = CH2, -CH2CH = CHphenyl , -CH (phenyl) 2, -C (phenyl) 3, tetrahydropyranyl, 4-methoxytetrahydropyranyl, 3-bromotetrahydropyranyl, tetrahydrothiopyranyl, 4-methoxytetrahydrothiopyranyl, tetrahydrofuranyl, tetrahydrothiofuranyl, and SiR1R2R3, each being R1, R2 and R2. C4, phenyl, benzyl, substituted phenyl or substituted benzyl, from a 4-0-protected cyclopentenone, said cyclopentenone dissolves in an organic solvent and the solution is treated with a Lewis acid and a reducer at a temperature between -100 ° C and 20 ° C. Procedures are also described for obtaining the enantiomers of said compound of formula (II) from the corresponding enantiomer of cyclopentenone, and procedures for obtaining said enantiomers of the compound of formula (II) and enantiomers of cis-4-0- esters. Protected-2-pentenyls from a racemic mixture of cyclopentenone by means of a suitable acylating agent.
priorityDate 1995-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67629189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427861277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457797818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559171

Total number of triples: 42.